Age-Stratified Performance of the Cervista HPV 16/18 Genotyping Test in Women with ASC-US Cytology | Citedby Results | Cancer Epidemiology, Biomarkers & Prevention | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Age-Stratified Performance of the Cervista HPV 16/18 Genotyping Test in Women with ASC-US Cytology

Cancer Epidemiol Biomarkers Prev (2011) 20 (6): 1185–1189.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSE CERVIX CANCER

Abdulhamit ÇALI
Rukiye ASLAN
Cem ÇELİK
Ahmet ALİM

Cumhuriyet Medical Journal (2023)

Role of Dual-Staining p16/Ki-67 in the Management of Patients under 30 Years with ASC-US/L-SIL

Cristina Secosan
Andrea Pasquini
Delia Zahoi
Andrei Motoc
Diana Lungeanu
Oana Balint
Aurora Ilian
Ligia Balulescu
Dorin Grigoras
Laurentiu Pirtea

Diagnostics (2022) 12 (2): 403.

Influence of co-infection complicated with human papillomavirus on cervical intraepithelial neoplasia development in patients with atypical squamous cells of undetermined significance

Hisami Kiseki
Yutaka Tsukahara
Natsumi Tajima
Ayako Tanaka
Aya Horimoto
Naohiko Hashimura

Journal of Infection and Chemotherapy (2017) 23 (12): 814.

Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia

N. Ari Wijetunga
Thomas J. Belbin
Robert D. Burk
Kathleen Whitney
Maria Abadi
John M. Greally
Mark H. Einstein
Nicolas F. Schlecht

Gynecologic Oncology (2016) 142 (3): 566.

Current Technologies and Recent Developments for Screening of HPV-Associated Cervical and Oropharyngeal Cancers

Sunny Shah
Satyajyoti Senapati
Flora Klacsmann
Daniel Miller
Jeff Johnson
Hsueh-Chia Chang
M. Stack

Cancers (2016) 8 (9): 85.

Human papillomavirus detection and genotyping, by HC2, full-spectrum HPV and molecular beacon real-time HPV assay in an Irish colposcopy clinic

Helen Keegan
Loretto Pilkington
Jamie McInerney
Csaba Jeney
Márta Benczik
Sinead Cleary
Gunther von Bunau
Michael Turner
Tom D’Arcy
Sharon O’ Toole
Borbála Pal-Szenthe
Borbàla Kaltenecker
Johanna Mózes
Anette Kovács
Agnes Solt
Noel Bolger
John O’Leary
Cara Martin

Journal of Virological Methods (2014) 201: 93.

Clinical Validation of the Cervista HPV HR Test According to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Cancer Screening

Aniek Boers
Rong Wang
Lorian Slagter-Menkema
Bettien M. van Hemel
Hilde Ghyssaert
Ate G. J. van der Zee
G. Bea A. Wisman
Ed Schuuring
Y.-W. Tang

Journal of Clinical Microbiology (2014) 52 (12): 4391.

Comparative study of the cervista and hybrid capture 2 methods in detecting high‐risk human papillomavirus in cervical lesions

Kun Tao
Jing Yang
Hua Yang
Zhen‐Hua Guo
Yue‐Mei Hu
Zhen‐Yu Tan
Feng Zhang
Jin‐Lin Duan

Diagnostic Cytopathology (2014) 42 (3): 213.

The role of human papillomavirus type 16/18 genotyping in predicting high‐grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results

Ming Guo
Yun Gong
Jianping Wang
Marilyn Dawlett
Shobha Patel
Ping Liu
Therese B. Bevers
Nour Sneige

Cancer Cytopathology (2013) 121 (2): 79.

Risk of Precancer Determined by HPV Genotype Combinations in Women with Minor Cytologic Abnormalities

Julia C. Gage
Mark Schiffman
Diane Solomon
Cosette M. Wheeler
Patti E. Gravitt
Philip E. Castle
Nicolas Wentzensen

Cancer Epidemiology, Biomarkers & Prevention (2013) 22 (6): 1095.